Genome-wide association studies in Alzheimer's disease
Open Access
- 6 October 2009
- journal article
- review article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 18 (R2) , R137-R145
- https://doi.org/10.1093/hmg/ddp406
Abstract
Genome-wide association studies (GWAS) have gained considerable momentum over the last couple of years for the identification of novel complex disease genes. In the field of Alzheimer's disease (AD), there are currently eight published and two provisionally reported GWAS, highlighting over two dozen novel potential susceptibility loci beyond the well-established APOE association. On the basis of the data available at the time of this writing, the most compelling novel GWAS signal has been observed in GAB2 (GRB2-associated binding protein 2), followed by less consistently replicated signals in galanin-like peptide (GALP), piggyBac transposable element derived 1 (PGBD1), tyrosine kinase, non-receptor 1 (TNK1). Furthermore, consistent replication has been recently announced for CLU (clusterin, also known as apolipoprotein J). Finally, there are at least three replicated loci in hitherto uncharacterized genomic intervals on chromosomes 14q32.13, 14q31.2 and 6q24.1 likely implicating the existence of novel AD genes in these regions. In this review, we will discuss the characteristics and potential relevance to pathogenesis of the outcomes of all currently available GWAS in AD. A particular emphasis will be laid on findings with independent data in favor of the original association.Keywords
This publication has 38 references indexed in Scilit:
- GAB2 as an Alzheimer Disease Susceptibility GeneArchives of Neurology, 2009
- Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's diseaseNature Genetics, 2009
- Genomewide Weighted Hypothesis Testing in Family-Based Association Studies, with an Application to a 100K ScanAmerican Journal of Human Genetics, 2007
- Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor GRB2 and Modulate ERK 1,2 SignalingPublished by Elsevier ,2007
- Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variantsHuman Molecular Genetics, 2007
- Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic PerspectiveCell, 2005
- Cloning and characterization of a novel Krüppel-like zinc finger gene, ZNF268, expressed in early human embryoBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 2001
- Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the blood-brain and blood-cerebrospinal fluid barriers.Proceedings of the National Academy of Sciences, 1996
- Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.Proceedings of the National Academy of Sciences, 1993